Form D · Biotechnology
Myrtelle Inc.
New York, NY · CIK 0001868532
Offering snapshot reported Jul 2, 2026 · SEC filing
- Reported sold
- $16.7M Offering amount: $30M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Jun 22, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 2, 2026 | Initial | $16,700,000 | No comparison | 3 | SEC filing |
| Dec 23, 2025 | Initial | $30,531,749 | No comparison | 21 | SEC filing |
| Mar 21, 2025 | Initial | $7,485,000 | No comparison | 1 | SEC filing |
| Jun 10, 2024 | Initial | $6,040,000 | No comparison | 11 | SEC filing |
| Oct 17, 2022 | Initial | $15,684,004 | No comparison | 6 | SEC filing |
| Jul 8, 2021 | Amendment | $13,500,000 | No comparison | Not reported | SEC filing |
| Jun 24, 2021 | Initial | $13,500,000 | No comparison | 27 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-589535
Source: Form D, filed Jul 2, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Thomas Barton | Director |
| Chrystyna Bedrij | Director |
| James Huang | Director |
| Michael Muhonen | Director |
| Laurie Platek | Director |
| Laurie Playtek | Executive |
| Mark Pykett | Director, Executive |
| Adrian Stecyk | Director, Executive |
| Fay Xing | Director |
| Debra Yu | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
17 State Street Fl3, Suite 350
New York, NY, 10004
Phone: (781) 621-2381
New York, NY, 10004
Phone: (781) 621-2381